|
Markt geschlossen -
NYSE
22:00:00 03.09.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 2.620 USD | +1.16% |
|
+5.65% | +45.56% |
| 12.08. | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 12.08. | Protalix BioTherapeutics, Inc. legt Ergebnisse für das zweite Quartal und das erste Halbjahr zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.16% | +5.65% | +10.55% | +31.66% | +45.56% | +59.76% | +32.32% | +66.88% | -56.33% | 209 Mio. | |
| -0.04% | -2.51% | +0.94% | +8.97% | +7.90% | +57.73% | +108.15% | +346.74% | +1’408.91% | 1’034 Mrd. | |
| +1.17% | +3.12% | +8.61% | +24.92% | +34.54% | +56.37% | +73.50% | +59.17% | +133.35% | 663 Mrd. | |
| -0.58% | -1.02% | +3.69% | +20.80% | +13.88% | +22.79% | +75.58% | +132.29% | +305.82% | 462 Mrd. | |
| +2.09% | -3.20% | +0.82% | +15.11% | +8.62% | +36.07% | +37.41% | -2.46% | +46.77% | 344 Mrd. | |
| 0.00% | +3.26% | +3.73% | +16.21% | +19.82% | +29.76% | +46.97% | +55.50% | +68.79% | 307 Mrd. | |
| +1.42% | -0.72% | -3.85% | -8.08% | -11.92% | +2.03% | +13.51% | +41.00% | +145.95% | 251 Mrd. | |
| +0.29% | +0.86% | +15.31% | +35.30% | +35.69% | +54.79% | +73.00% | +96.55% | +161.60% | 239 Mrd. | |
| -0.03% | -1.11% | -1.62% | +8.61% | -7.29% | -15.87% | -53.65% | -5.01% | +97.87% | 207 Mrd. | |
| +1.08% | +2.11% | +16.14% | +18.54% | +23.20% | +34.17% | +97.29% | +109.04% | +96.67% | 186 Mrd. | |
| -0.72% | +1.80% | +15.19% | +12.76% | +15.70% | +15.33% | -19.48% | -38.49% | -17.14% | 165 Mrd. | |
| +0.22% | +1.95% | +16.95% | +31.26% | +23.07% | +39.14% | +58.92% | +180.07% | +486.65% | 141 Mrd. | |
| +0.64% | +0.77% | +4.26% | +25.03% | +26.23% | +43.62% | +9.79% | +2.98% | +20.83% | 138 Mrd. | |
| -1.15% | -2.58% | +2.42% | +3.88% | -7.80% | -9.75% | -22.65% | -13.53% | +8.57% | 107 Mrd. | |
| +0.27% | -1.74% | -3.37% | +2.53% | +2.30% | +29.39% | +34.51% | +1.15% | -9.78% | 101 Mrd. | |
| +0.67% | -2.45% | -0.78% | -9.71% | -16.56% | +5.69% | +55.79% | +59.21% | +507.78% | 70.85 Mrd. | |
| +1.44% | +0.82% | +7.16% | +21.81% | +22.19% | +30.85% | +31.00% | +60.15% | +25.44% | 58.62 Mrd. | |
| +0.33% | +0.47% | +2.68% | +44.69% | +33.32% | +79.84% | -3.01% | +3.46% | -48.02% | 56.01 Mrd. | |
| +0.86% | -1.67% | -15.01% | -5.04% | -22.85% | -33.27% | +10.67% | +0.22% | +178.29% | 44.63 Mrd. | |
| -2.30% | -4.21% | -1.57% | +11.44% | -4.59% | -1.54% | +11.78% | - | - | 43.54 Mrd. | |
| Durchschnitt | +0.34% | -0.54% | +4.11% | +15.53% | +12.05% | +26.84% | +33.57% | +60.79% | +187.47% | 230.99 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.48% | -0.75% | +4.41% | +15.43% | +13.97% | +36.15% | +57.30% | +121.02% | +425.85% |
- Börse
- Aktien
- A2PWSL Aktie
- Sektor Protalix BioTherapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
